Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...

Millions of Brits have been warned to stay away from one particular fruit, as studies suggest it could pose a risk to the health of those who take certain medication.

Thousands of babies have been born hooked on drugs in England over the past decade, new data has revealed. More than 1,000 newborns have received treatment in England’s hospitals each year since 2014 ...

The forced swim test has been under scrutiny for its dubious validity. An independent report by the Animals in Science ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.